These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8612318)

  • 21. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer.
    Kosmas C; Tsavaris N; Koutras A; Makatsoris T; Mylonakis N; Tzelepis G; Dimitrakopoulos A; Spyropoulos K; Polyzos A; Karabelis A; Kalofonos HP
    Oncology; 2005; 69(4):333-41. PubMed ID: 16282711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.
    Shepherd FA; Goss PE; Latreille J; Stewart D; Logan D; Evans WK; Maroun J; Warner E
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):19-23. PubMed ID: 2159185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer.
    Feld R; Wierzbicki R; Walde PL; Shepherd FA; Evans WK; Gupta S; Shannon P; Lassus M
    J Clin Oncol; 1992 Feb; 10(2):297-303. PubMed ID: 1310105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated dose.
    Quantin X; Rivière A; Daurès JP; Oliver P; Comte-Bardonnet M; Khial F; Marcillac I; Pujol JL
    Am J Clin Oncol; 2000 Apr; 23(2):192-6. PubMed ID: 10776983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of non-small cell lung cancer with ifosfamide (IFO)+ 4'-epiadriamycin (EPI)+platinum vs. IFO+EPI: a GETLAC Study. Grupo de Estudio y Tratamiento Latinoamericano del Cáncer Study.
    Brocato N; Bruno MF; Araujo CE; Cervellino JC; Pirisi C; Temperley G; Sparrow C; Savulsky C; Balbiani LR
    Oncology; 1995; 52(1):24-31. PubMed ID: 7800338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I study of paclitaxel (Taxol) and ifosfamide in previously untreated patients with advanced non-small-cell lung cancer. A study of the National Cancer Institute of Canada Clinical Trials Group.
    Shepherd FA; Latreille J; Crump M; Stewart D; Tomiak E; Eisenhauer E; Fisher B
    Ann Oncol; 1996 Mar; 7(3):311-3. PubMed ID: 8740797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer.
    Chen YM; Perng RP; Yang KY; Lin WC; Wu HW; Liu JM; Tsai CM; Whang-Peng J
    Am J Clin Oncol; 2000 Feb; 23(1):13-7. PubMed ID: 10683066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer.
    Baka S; Manegold C; Buchholz E; Schott-von-Römer K; Lorigan P; Nagel S; Blackhall F; Aschroft L; Thatcher N
    Lung Cancer; 2006 Aug; 53(2):165-70. PubMed ID: 16787686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.
    Miller VA; Rigas JR; Pisters KM; Grant SC; Pfister DG; Heelan RT; Kris MG
    Am J Clin Oncol; 1995 Aug; 18(4):303-6. PubMed ID: 7625371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-based phase I trial of irinotecan and epirubicin.
    Lau D; Johl J; Huynh M; Davies A; Tanaka M; Lara P; Gandara D
    Am J Clin Oncol; 2008 Jun; 31(3):226-30. PubMed ID: 18525299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epirubicin and ifosfamide in advanced soft tissue sarcoma: a phase II study.
    Chevallier B; Leyvraz S; Olivier JP; Fargeot P; Facchini T; Vo Van ML
    Cancer Invest; 1993; 11(2):135-9. PubMed ID: 8462014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II study of intensive-dose epirubicin/verapamil as induction therapy followed by intensive-dose ifosfamide for advanced breast cancer.
    Langenbuch T; Mross K; Jonat W; Hossfeld DK
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S93-6. PubMed ID: 2347058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of metastatic breast cancer with the combination of ifosfamide, epirubicin and 5-fluorouracil.
    Ghavamzadeh A
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S66-8. PubMed ID: 2347052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.
    Smit EF; Piers DA; Postmus PE
    Eur J Cancer; 1992; 28A(12):1965-7. PubMed ID: 1329882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I study of a combination of irinotecan and ifosfamide in advanced primary lung cancer.
    Ichiki M; Rikimaru T; Okubo Y; Gohara R; Mitui T; Kawayama T; Kinoshita M; Oizumi K
    Kurume Med J; 1999; 46(2):111-5. PubMed ID: 10410530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose epirubicin for untreated patients with advanced tumours: a phase I study.
    Martoni A; Melotti B; Guaraldi M; Pacciarini MA; Riva A; Pannuti F
    Eur J Cancer; 1990; 26(11-12):1137-40. PubMed ID: 1963544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of high-dose epirubicin in non-small cell lung cancer.
    Wils J; Utama I; Sala L; Smeets J; Riva A
    Eur J Cancer; 1990; 26(11-12):1140-1. PubMed ID: 1963545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epirubicin and ifosfamide in patients with refractory breast cancer and other metastatic solid tumours.
    Hoffmann W; Weidmann B; Migeod F; Könner J; Seeber S
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S69-70. PubMed ID: 2347053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study.
    Palumbo R; Neumaier C; Cosso M; Bertero G; Raffo P; Spadini N; Valente S; Villani G; Pastorino M; Toma S
    Eur J Cancer; 1999 Jan; 35(1):66-72. PubMed ID: 10211090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.